top of page

Search Results

Results found for "Dongbo Bu"

  • GPCR Collaboration: From Models to Medicine

    From Lone Modeler to Collaborative Architect Carlsson’s lab is built to plug directly into a larger ecosystem Experimentalists often hesitate to rely on computational predictions, especially when burned in the past Over time, that transparency has built enduring partnerships , including one of Carlsson’s earliest with It’s built on trust between scientists. GPCR Podcast 🌱 Build a career with purpose, not just papers The Dr.

  • Predicting GPCR Function: Inside the Carlsson Lab’s Modeling Toolbox

    Watch Episode 175 If your model can’t predict the future of GPCR drug discovery, why build it at all? For dopamine receptor studies, they built predictive models before experimental structures were available But success depends on researchers who can manage expectations, build trust, and integrate across disciplines Jens Carlsson breaks down the tools, challenges, and mindset behind building models that don’t just explain—they

  • Accelerating GPCR Drug Discovery: What 40 Years of Pharmacology Reveal

    That’s exactly what Terry’s Corner  was built to do: bring four decades of frontline discovery insight Every misaligned study is not just wasted budget—it’s lost time. Program Kill vs. It’s less bureaucratic than most outsiders think.

  • From Failed Experiments to Predictive GPCR Models

    a growing pharmacological interest, GPCRs presented the perfect challenge for someone who wanted to build

  • Irreversible Drugs, Real Control: Design for Durable Target Engagement

    Your Membership Gives You: Proven frameworks used in real discovery programs On-demand lessons built

  • Innovative Data-Driven Solutions: The pHSense Revolution

    of scaffold families Key milestone: Clean signal in endogenous beta cells Revvity commercial launch Building Build or adopt assays that can evolve with your questions—like pHSense.” What’s Next? GPCR innovators, exclusive deep-dives, and practical tools to accelerate your research or career. 👥 Build

  • Transformative GPCR Insights: Unleash New Horizons in Science | Sep 9 - 15, 2024

    Burger , Arthur Christopoulos , David M. 🚨 Hurry to reserve your spot for the Principles of Pharmacology I & II BUNDLE before the Early

  • Beyond Clearance: The Strategic Power of Irreversible Drug Binding

    Irreversible binding isn’t a magic bullet. It’s a double-edged sword. Terry’s Corner and get: Frameworks proven in real discovery programs On-demand lessons  designed for busy That’s why discovery teams turn to Terry’s Corner: to build strategies that anticipate these collisions If you’re not designing with persistent enzyme interactions in mind, you’re building risk into your molecule

  • How Breakthroughs Happen: Eric Trinquet on Innovation, Serendipity & GPCRs

    If you’re building tools or careers in GPCR science, this is your playbook. Eric Trinquet Built to Fail, Built to Win: Inside the IP1 Assay Origin Story The IP-One assay didn’t The pHSense Breakthrough: Two Dimensions of Discovery pHSense wasn’t built in a vacuum—it was born from From Theory to Tool: How Great Products Get Built pHSense didn’t materialize overnight. Build theories, but be ready to toss them.

  • Understanding Enzyme Inhibition In GPCR Discovery Programs

    Your Membership Gives You: Proven frameworks used in real discovery programs On-demand lessons built for busy scientists A voice in future course topics Fresh, weekly content that stays relevant Live monthly Whether you’re building assays or a scientific career, this is a must-read on why risk, surprise, and It’s built for scientists and teams who want fewer tabs and faster decisions—one scroll that blends structure

  • Enzyme Inhibition Pharmacology: The Hidden Gatekeepers of GPCR Drug Discovery

    twice—first by its receptor, then by its enzymes.Ignoring the second gatekeeper means wasting cycles, budgets Your Membership Includes: Frameworks proven in real discovery programs On-demand lessons  designed for busy

  • Assay Volume Control: Your GPCR Drug Discovery Power Lever

    gives you:   Proven   frameworks  for real-world GPCR drug discovery Flexible , on-demand lessons for busy the curriculum with your topic suggestions Weekly new releases  to stay ahead of the science Content built It’s built to compress your time to clarity—so you can pick better targets, stress-test hypotheses earlier Acting on the right signals today prevents tomorrow’s delays—and puts you ahead when budgets and timelines

  • The Truth About GPCR Product Launches: Years in the Making

    Built to Fail, Built to Win: The IP One Gamble After the success of their cAMP assay, Trinquet’s team The goal wasn’t to build a pH sensor—it was to create brighter, more stable lanthanide complexes for It’s when the tools you built in-house meet the problems no one saw coming. pHSense isn’t just a probe GPCR innovators, exclusive deep-dives, and practical tools to accelerate your research or career. 👥 Build

  • Assay Sensitivity: The Hidden Lever Driving GPCR Drug Discovery

    Why Members Join: Frameworks proven in discovery programs On-demand lessons built for busy scientists

  • Orthosteric vs Allosteric Interactions— and the pHSense Shift in Internalization

    membership gives you:   📚 Proven frameworks for real-world discovery 🌍 Flexible, on-demand lessons for busy curriculum with your topic suggestions 🆕 Weekly new releases to stay ahead of the science 🧠 Content built

  • Orthosteric vs. Allosteric Interactions: The Silent Decider of Safety and Success

    But here’s the truth: too many programs still fail because early decisions were built on shaky mechanistic For teams building structure–activity relationships (SAR), this insight is gold: you’re not just chasing membership gives you:   📚 Proven frameworks for real-world discovery 🌍 Flexible, on-demand lessons for busy curriculum with your topic suggestions 🆕 Weekly new releases to stay ahead of the science 🧠 Content built

  • How to Design GPCR Drugs That Work in Vivo: Strategy, Tools, and Insights

    Breakthroughs this week: Lilly to build $5B manufacturing facility in Virginia; Novo Nordisk flags drug GPCR Podcast, the Revvity team built pHSense™ from the ground up by listening to what GPCR scientists

  • Why Opposing Processes Matter for Your Next GPCR Drug

    If your job is to move molecules confidently toward the clinic, this is a blueprint for building a more

  • Dr. GPCR Spotlights Revvity’s pHSense™ Internalization Tools

    A GPCR Internalization Tool Designed for Real Research Needs Built on more than two decade A GPCR Internalization

  • How Advanced GPCR Kinetics Sharpen Decision Making (and Save You Time)

    It’s built for the GPCR community—by people who live the science—so you spend less time sifting and more

  • GPCR Drug Discovery at Discovery on Target: Why This Track Is About More Than Receptors

    Over the years, we’ve built a global network of researchers, biotech leaders, and pharma innovators who

  • The Five Traps of Ignoring Kinetics

    It’s the difference between building a solid pipeline and chasing ghosts.

  • Mechanism vs. Assumption: A Model-First Path to Getting GPCR MoA Right

    It’s built for scientists and leaders who want the signal, not the scroll: frameworks that clarify mechanism

  • From Snapshots to Predictions: Why Mechanism of Action Matters

    But you can build confidence through iteration. It’s learning how to design, interpret, and decide with models built in . Built for discovery-phase teams, pharmacologists refining fundamentals, scientists challenging legacy

  • How a Failed Med School Dream Sparked a GPCR Biotech Revolution

    Blue Therapeutics: Turning GPCR Biology Into a Business Ajay’s academic training planted the seeds for It was investor rejections, endless slide decks, and the steep learning curve of biotech business. narratives, navigating startup fundraising, and building an operational team. Superluminal is building systems that learn from receptor movement, conformational shifts, and complex By staying grounded in scientific rigor while embracing the tools of business and technology, he’s built

  • GPCR Happy Hour – Boston, Sept 2025

    GPCR is a nonprofit global community  dedicated to building a strong, connected GPCR ecosystem. be part of the conversations that will ripple far beyond Boston. ✨ GPCR Happy Hour: Where science, business

  • Curve Shifts Don’t Lie, But Your Eyes Might

    By the end, you’ll know how to choose the right test, design experiments with power built in, and validate It’s learning how to design, analyze, and decide with confidence built in.

  • Understanding the Journey: Catherine Demery's Path to Addiction Science

    It was here that the disciplined structure of industry science helped her re-find purpose and build confidence alcoholism and opioid addiction—a decision that would reshape her academic ambitions. “...I had a light bulb Industry can build skills that academia often overlooks.

  • Purpose-Driven Opioid Research: Catherine Demery’s Academic Path

    Careers built on prestige, titles, or external pressure can burn out quickly. But careers built on urgency, alignment, and meaning are the ones that last. It was the first time late nights in the lab weren’t a burden but a sign of genuine engagement. Real-world data should guide how we build preclinical models.

  • Allosteric Binding Demystified: Smarter GPCR Drug Discovery

    Sharpen your discovery decisions ➤ Yamina’s Corner - The Hidden Cost of Busy A GPCR program can collapse—not Stop wasting talent:  When senior leaders spend nights copy-pasting data, your burn rate accelerates

bottom of page